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ABSTRACT
Limiting food intake attenuates many of the deleterious effects of aging, 
impacting upon healthspan and leading to an increased lifespan. Whether it is the 
overall restriction of calories (calorie restriction: CR) or the incidental reduction in 
macronutrients such as protein (protein restriction: PR) that mediate these effects is 
unclear. The impact of 3 month CR or PR, (10 to 40%), on C57BL/6 mice was compared 
to controls fed ad libitum. Reductions in circulating leptin, tumor necrosis factor-α and 
insulin-like growth factor-1 (IGF-1) were relative to the level of CR and individually 
associated with morphological changes but remained unchanged following PR. Glucose 
tolerance and insulin sensitivity were improved following CR but not affected by PR. 
There was no indication that CR had an effect on oxidative damage, however CR 
lowered antioxidant activity. No biomarkers of oxidative stress were altered by PR. CR 
significantly reduced levels of major urinary proteins suggesting lowered investment 
in reproduction. Results here support the idea that reduced adipokine levels, improved 
insulin/IGF-1 signaling and reduced reproductive investment play important roles in 
the beneficial effects of CR while, in the short-term, attenuation of oxidative damage 
is not applicable. None of the positive effects were replicated with PR.
INTRODUCTION
Calorie restriction (CR) is the most consistent 
intervention known to improve healthspan and delay the 
aging process [1–4]. Although the exact mechanisms 
underlying the beneficial effects of CR remain unclear, 
several physiological adaptations to CR are associated 
with an extension in longevity. First, the prevention of 
obesity/lowering fat mass, particularly visceral fat [5–8], 
reductions in glucose and insulin levels improving insulin 
sensitivity [9–12], a reduction in oxidative stress and/or 
increase in antioxidant defense mechanisms [13–16], and 
a reduction in body temperature [17].
A comprehensive analysis of body composition 
responses to graded levels of CR [18] highlighted the 
preferential utilization of adipose tissue, but also that 
reductions occur in lean tissue mass and masses of the 
vital organs. Adipose tissue is an efficient energy store as 
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well as a major endocrine organ from which adipokines 
are derived [19, 20]. Interestingly some of the longest 
living mutant mouse models, Ames and Snell dwarf mice, 
which can live >50% longer than wild type siblings, are 
also relatively obese. Although these dwarf mice exhibit 
diminished visceral fat depots, their subcutaneous depots 
are larger and may be related to their improved metabolic 
activity [11, 21] in that while visceral fat is associated 
with insulin resistance, higher risk of type II diabetes, 
dyslipidemia, and mortality [22–24], subcutaneous fat is 
associated with improved insulin sensitivity, a lower risk 
of developing type II diabetes and as indicated by these 
long lived models, an extended lifespan [24–26].
Following CR, decreases in fat mass result in a 
concomitant reduction in fat derived hormones such as 
leptin, a key regulator of long-term energy balance [27]. 
Leptin and insulin resistance are both associated with aging 
and much evidence exists to show the amelioration of 
these metabolic disorders by CR [28–30]. The metabolic 
pathways controlling energy metabolism appear to be 
especially important in the regulation of aging and longevity 
[31–33]. Lean tissue is also now widely recognized as a 
source of endocrine factors [34]. Reductions in lean tissue 
mass may be expected to influence levels of interleukin-6 
(IL-6) and insulin-like growth factor-1 (IGF-1) which 
impact on insulin disposal capability. In fact, growth 
hormone (GH)/IGF-1 and insulin signaling, one of the most 
evolutionary conserved pathways, has strong associations 
with aging [10]; reviewed in [35]. The long lived Ames, 
Snell and the GH receptor knockout dwarf mice all have 
reductions in GH, IGF-1 and improved insulin sensitivity 
[36–39]. It seems no coincidence that both the extension 
of lifespan mediated by CR and the long lived GH mutant 
mice models result in a reduced body size. Miller et al’s 
2002 paper “Big mice die young” found early life body 
weight can predict longevity in 4 mutant dwarf mice models 
[40]. On the other hand mice overexpressing GH are larger 
in size but with lowered adiposity and a drastically reduced 
lifespan compared to controls [21, 41]. Thus, while a larger 
body size is one of the best predictors of a longer life span 
across species, within species, it is the smaller animals that 
live longest and the larger are shorter lived [42, 43].
Ames and Snell dwarf mice also exhibit elevated 
antioxidant profiles, lower production of reactive oxygen 
species (ROS) and less oxidative damage, which are also 
characteristic of CR. Many have postulated that the life-
extension effects of CR result from the attenuation of age-
related oxidative stress [14, 16, 44–47]. However, results 
from these and other studies are inconsistent and exactly 
how these changes are facilitated by CR remains unclear. 
Although the free radical theory of aging (FRTA) is one 
of the most popular theories of aging [48–51] this has 
recently been called in to question [52–54].
Investment in antioxidant protection however, is 
potentially energetically costly therefore there is an anomaly 
in the upregulated response of this system in animals that 
are under restricted energy supply. A resolution of this 
anomaly is provided by evolutionary considerations of the 
effects of CR [55]. In particular under restriction animals 
may not have sufficient energy to sustain reproduction which 
is energetically costly [56, 57] and generally CR results 
in infertility but this is dependent on sex, level of CR and 
age [2, 58]. It is suggested therefore that under CR animals 
may shut down their reproductive activity and divert the 
saved energy towards mechanisms such as antioxidant 
protection that protect the soma, thereby increasing lifespan. 
However measurements of reproductive investment are 
hard to determine in mice denied access to individuals 
with which to mate. While reproductive effort for females 
is energetically expensive, particularly during lactation, for 
males reproductive costs include investment in territorial 
scent marking which can relay information regarding sex, 
reproductive and health status from which a female mouse 
can determine her selection of a mate [59]. The urine of mice 
contains a collection of proteins referred to as major urinary 
proteins (MUPs) which play an important role in scent 
marking [60, 61]. The production of MUPs from the liver 
and salivary glands together with other androgen-dependent 
volatile signals such as farnesenes produced in the preputial 
glands [59] may accrue oxidative damage. Thus, according 
to the trade-off theory between reproduction and somatic 
protection mice should alter their investment in scent marking 
by lowering production of urinary MUPS as they shut down 
reproductive process to save energy [62].
The purpose of this study was to characterize the 
impact of CR in the male C57BL/6 mouse on four proposed 
mechanisms by which a reduced food intake may alleviate 
the aging process. 1) a reduced level of body fat and hence 
inflammatory adipokines [6, 63–65], 2) alterations in the 
insulin/IGF-1 signaling pathways and hence improved 
glucose homeostasis [66, 67], 3) lowered oxidative damage 
and/or increased antioxidant capacity [14, 15], and 4) 
reduced reproductive investment (in MUPs) [58, 69]. In 
the majority of studies indicating a beneficial effect of CR 
on the life span, there was a parallel reduction in dietary 
protein supply, which led some to suggest the promotion 
of longevity is at least in part due to protein restriction 
(PR) [70]. Here we investigated the physiological outcome 
of a graded series of CR, where both protein and calories 
were reduced, and PR, where diets were isocaloric and the 




A gradation in the response to CR was observed in 
circulating leptin levels (One way ANOVA: F
5,35
 = 14.96, 
p < 0.0005) (Figure 1a) with leptin levels lower relative to 
the 12AL control group (food available ad libitum in 12 h 
dark period) (3.9 ±1.02 ng/ml) in the mice where food was 
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Figure 1: Hormonal changes measured in male C57BL/6 mice following calorie restriction (CR). Mice were fed 12 or 24 
hrs ad libitum (12AL or 24AL) or calorie restricted (CR) by 10, 20, 30 or 40% (10CR, 20CR, 30CR and 40CR) for 3 months. Circulating 
levels of a. leptin, c. tumor necrosis factor (TNF)-α, d. insulin-like growth factor (IGF-1) and f. insulin. Significant hormonal relationships 
are shown between b. fat mass and leptin, e. structural tissues and IGF-1, g. vital organs and insulin and h. liver and insulin. Results are 
expressed as mean ± sem. Different letters denote significant differences between treatment groups.
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restricted by 20%, 30% and 40% (1.10 ± 0.16, 0.73 ± 0.16, 
0.53 ± 0.28 ng/ml 20CR, 30CR and 40CR respectively, 
post-hoc Tukey p < 0.01) (Figure 1a). Consequently, level 
of restriction was negatively related to the circulating 
leptin levels (least squares regression: F
1,39
 = −79.01, 
p < 0.0005, r2 = 0.67). When we entered the masses of the 
different body compartments into a multiple regression 
model, along with the level of restriction, the significant 
predictors were the summed masses of white adipose 
tissue (T = 7.89, p < 0.0005: Figure 1b), structural tissue 
(T = −2.68, p = 0.011) and mass of the reproductive organs 
(T = 2.27, p = 0.029), with the overall regression explaining 
84.9% of the variation in circulating leptin levels (F
3,37
 = 
69.28, p < 0.0001). The masses of the alimentary tract and 
vital organs were not significant predictors (p > 0.05). Within 
the body fat compartment, circulating leptin was related 
to the masses of subcutaneous (T = 3.11, p = 0.004) and 
epididymal fat stores (T = 21.98, p = 0.056: overall regression 
r2 = 0.802, F
2,38
 = 77.03, p < 0.0005) but not the masses of 
the retroperitoneal or mesenteric fat stores (p > 0.05 in both 
cases). Within the reproductive organs the significant predictor 
was the mass of the reproductive accessory organs (T = 5.46, 
p = 0.0005) and not the mass of the testes (p > 0.05).
Plasma TNF-α levels (One way ANOVA: F
5,34
 = 
6.15, p < 0.0005) were also significantly lower with 30CR 
and 40CR (1.45 ± 0.10 and 1.82 ± 0.17 pg/ml) when 
compared to 12AL (3.08 ± 0.41 pg/ml, post hoc Tukey: 
p < 0.05) (Figure 1c), and hence TNF-α was significantly 
negatively related to the level of restriction (least squares 
regression; F
1,38
 = −24.01, p < 0.0005, r2 = 0.387). None of 
the masses of the different body compartments entered were 
significant predictors of the circulating level of TNF-α. CR 
treatment was also a significant factor affecting levels of 
IL-6 (One way ANOVA: F
5,35
 = 4.75, p < 0.01), however, 
IL-6 levels were not systematically related to the level 
of restriction (least squares regression: F
1,39
 = 1.13, p = 
0.29). The levels were similar in the 12AL, 10CR (10% 
restriction) and 30CR, and were higher in the 24AL (24 h 
ad libitum access to food), 20CR and 40CR (not shown). 
Nevertheless, circulating IL-6 levels were significantly 
associated with the total mass of the alimentary tract 
(multiple regression: F
1,39
 = 5.82, p = 0.021, r2 = 0.129), 
and more specifically the mass of the stomach (F
1,39
 = 4.93, 
p = 0.032). No association between CR level and the level 
of resistin was observed (F
5,35
 = 0.63, p > 0.05, not shown), 
but there was a significant relationship between circulating 
resistin levels and the mass of structural tissue (least squares 
regression: F
1,39
 = 5.32, p = 0.027, r2 = 0.119). No other 
tissue compartments were significantly associated to resistin 
levels in the multiple regression analysis.
There was a strong effect of the level of CR on 
plasma IGF-1 levels (One way ANOVA: F
5,38
 = 6.56, 
p < 0.0005) with significantly lower levels in the 40CR 
mice relative to 12AL mice (129.21 ± 9.68 versus 201.33 ± 
9.06 ng/ml, post hoc Tukey: p < 0.05) (Figure 1d).When we 
entered level of restriction and the masses of the different 
body compartments into a multiple regression model, the 
circulating IGF-1 levels (logged) were strongly related to 
the mass of structural tissue (Regression; F
1,42
 = 47.21, p < 
0.0005, r2 = 0.53: Figure 1e) but not to level of restriction, 
or the masses of any other body compartment. Fasted 
plasma insulin levels, were reduced by CR relative to 12AL 
(One-way ANOVA: F
5,35
 = 5.56, p < 0.001, Figure 1f) with 
levels significantly lower compared to 12AL at restriction 
levels of 20% and above (post hoc Tukey: p < 0.05). 
Circulating insulin was strongly related to the total mass 
of the vital organs (least squares regression; F
1,39
 = 16.15, 
p < 0.0005, r2 = 0.293: Figure 1g). Insulin was not related 
to the mass of any other tissue group, or level of restriction 
in the multiple regression model. Among the different vital 
organs, when entered into the model separately, the only 
significant factor influencing the circulating insulin levels 
was mass of the liver (least squares regression; F
1,39
 = 
16.83, p < 0.0005, r2 = 0.314: Figure 1h).
Intraperitoneal glucose tolerance tests (IPGTT)
There were no significant differences in fasting 
glucose between the 6 diet groups measured at baseline 
(F
5,42
 = 0.94, p > 0.05) (Figure 2a). Average fasting glucose 
at baseline was 10.28 ± 0.74 mmol/l. The level of CR was 
not a significant factor influencing the level of fasting 
glucose over the treatment period (GLM-RM, F
5,42
 = 1.725, 
p > 0.05, Figure 2a). However, there was a significant 
time effect when comparing baseline levels against that 
following 3 months treatment (GLM-RM, F
1,42
 = 49.477, 
p < 0.001) and a significant interaction between time and 
the level of CR (F
5,42
 = 8.269, p < 0.001). While fasting 
glucose levels between both AL groups did not differ over 
the 3 months (paired t-test, 12AL : t7 = 0.549, p > 0.05, 
24AL : t
8
 = −1.818, p > 0.05), a significant decrease in 
fasting glucose was recorded in all CR groups (paired 
t-test, 10CR : t7 = 4.283, p < 0.01, 20CR : t7 = 2.734, p < 0.05, 
30CR : t
6
 = 4.975, p < 0.01, 40CR : t
8
 = 5.213, p < 0.001, 
Figure 2a). After 3 months of treatment fasting glucose 
levels were significantly lowered (One way ANOVA: F
5,47
 
= 7.326, p < 0.001) in mice under restrictions of 20CR and 
higher compared to 12AL (post hoc Tukey: 20CR: 7.562 ± 
0.665 mmol/l, p < 0.001, 30CR: 7.229 ± 0.711 mmol/l, p < 
0.05, 40CR: 7.122 ± 0.627 mmol/l, p < 0.01, Figure 2a). In 
a multiple regression analysis fasting glucose at 3 months 
was significantly positively related to the circulating IGF-1 
levels (T = 4. 11, p < 0.0005: Figure 2b) and circulating 
insulin levels (T = 3.69, p < 0.001: Figure 2c), with the 
overall regression explaining 56.1% of the variation 
in fasting glucose (least squares multiple regression: 
F
2,38
 = 24.27, p < 0.0005). In this analysis fasting glucose 
was not related to the levels of any other measured 
hormones, the sizes of the different body compartments, or 
the level of restriction.
Glucose clearance after 15 mins was much quicker 
following 3 months of CR compared to 60 mins in both AL 
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Figure 2: The effect of graded levels of calorie restriction (CR) on glucose homeostasis. a. Fasting glucose concentrations 
at baseline (BL) and following 3 months of CR (F). Strong relationships between fasting glucose and b. IGF-1 and c. insulin were found. 
d. Glucose concentrations measured over 120 minutes following glucose injection evaluated after 3 months of CR, e. glucose tolerance 
calculated as area under the curve (AUC). f. Relationship between reproductive organs and AUC and g. insulin and AUC. Mice were fed 
graded levels of calorie restriction (CR) (10CR, 20CR, 30CR and 40CR) and control groups were fed ad libitum (AL) for 12 or 24 hrs 
(12AL or 24AL). Different letters within a time point indicate significant differences between groups. Data represented as mean ± sem.
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groups (Figure 2d). To evaluate this response the total area 
under the curve (AUC) was analyzed; a significant effect of 
time (GLM-RM, baseline v 3 months: F
1,42
 = 8.353, p < 0.001), 
CR level (F
5,42
 = 2.66, p < 0.05) and a significant interaction 
(F
5,42
 = 12.084, p < 0.001) were found (Figure 2e). Comparisons 
of AUC after 3 months CR (One-way ANOVA: F
5,47
 = 8.800, 
p < 0.001) to the AUC at baseline revealed an improvement 
in glucose tolerance with all levels of CR relative to the 12AL 
group (post hoc Tukey: p < 0.01). In contrast a negative effect 
of time on glucose tolerance was found in the 24AL group 
(AUC baseline versus 3 months, paired t-test, t = −2.557, 
p < 0.005) (Figure 2e). In the multiple regression analysis 
two factors emerged as significant predictors of AUC. The 
most significant factor was the mass of the reproductive 
organs (T = 6.84, p < 0.0005: Figure 2f), and in particular 
the mass of the reproductive accessory organs (T = 3.71, 
p = 0.001) rather than the mass of the testes (p > 0.05). 
The level of circulating insulin was also significantly 
related to the AUC (T = 3.00, p = 0.005, overall regression 
including both predictors F
2,38
 = 26.11, p < 0.0005, 
r2 = 0.579, Figure 2g).
An improvement in insulin sensitivity is a key 
feature of the CR response. Insulin sensitivity, assessed 
using the Homeostasis model assessment (HOMA2), 
was improved by CR (One way ANOVA: F
5,39
 = 5.98, 
p < 0.001), significantly so in the 20CR (78.83 ± 6.49%, 
post hoc Tukey: p < 0.05) and 40CR groups (80.89 ± 
13.87%, post hoc Tukey: p < 0.05) relative to 12AL (38.63 
± 5.83%) (Figure 3a). Insulin sensitivity was strongly 
negatively associated with variation in the circulating 
levels of insulin (F
1,36
 = −449.42, p < 0.0005, r2 = 0.92: 
Figure 3b), which was not surprising as insulin levels 
are part of the HOMA2 calculation (see Materials and 
Methods). No other factors entered as significant predictors 
of insulin sensitivity. HOMA2 also gives an indication 
of insulin resistance (One way ANOVA: F
5,39
 = 6.96, 
p < 0.001) which was significantly increased in the 20CR 
(1.343± 0.14, post hoc Tukey: p < 0.01) and the 40CR 
groups (1.586 ± 0.05, post hoc Tukey: p < 0.05) relative 
to the 12AL animals. As with insulin sensitivity, insulin 
resistance was strongly influenced by circulating insulin 
levels (least squares regression: F
1,39
 = 156.92, p < 0.0005, 
r2 = 0.878: Figure 3c). In addition insulin resistance was 
associated with circulating levels of TNF-α (T = 2.76, 
p = 0.009) and circulating levels of  IL-6 (T = 2.81, p = 
0.008). The overall regression including all 3 predictors: 
F
3,36
 = 78.84, p < 0.0005, r2 = 0.806. These analyzes helped 
us infer the relationships between the level of CR, body 
composition changes, circulating hormone levels and 
parameters of glucose homeostasis (Figure 4).
Markers of oxidative stress
Significant variation in the levels of all three 
enzymatic antioxidants was observed in the liver in 
response to CR (Figure 5a, 5b, 5c). Catalase activity was 
significantly affected by the CR manipulation (One way 
ANOVA: F
5,48
 = 5.16, p < 0.001) and animals on 40CR 
had significantly lower levels of catalase in comparison 
to 12AL (post hoc Tukey: p < 0.01; Figure 5a). The 
activity of superoxide dismutase (SOD) also varied with 
the treatment (One way ANOVA: F
5,46
 = 3.30, p = 0.013) 
and similar to catalase was decreased following 40CR as 
well as 20CR relative to 12AL (post hoc Tukey: p < 0.05, 
Figure 5b). Finally, Glutathione peroxidase (GPx) levels 
were significantly impacted by the CR treatment (One 
way ANOVA: F
5,46
 = 3.17, p < 0.05) and were decreased 
significantly in the 10CR group relative to 12AL (post 
hoc Tukey: p < 0.05; Figure 5c). As with catalase and 
SOD, GPx activity was lowered with 40CR but did not 
reach significance (post hoc Tukey: p < 0.052; Figure 5c). 
Levels of all three enzymatic antioxidants were positively 
correlated with each other (Pearson correlation: all 
p < 0.001). The activity of catalase was associated 
positively with both the mass of structural tissue (T = 6.80, 
p < 0.0005; Figure 5d) and the mass of the alimentary 
tract (T = 3.36, p = 0.002): overall least squares regression 
F
2,45
 = 25.59, p < 0.0005, r2 = 0.532, but was not 
significantly linked to any of the circulating hormone 
levels or masses of other tissues, or the level of restriction. 
In contrast, activity of GPx was positively associated with 
the total mass of the vital organs (T = 3.97, p < 0.0005; 
Figure 5e) and negatively linked to both circulating TNF-α 
levels (T = −1.84, p = 0.044) and circulating IGF-1 levels 
(T = −3.08, p = 0.004): overall least squares regression 
F
3,36
 = 5.31, p = 0.004, r2 = 0.307. Masses of no individual 
vital organs were significantly associated to GPx levels 
(p > 0.08 in all cases). In the multiple regression analysis, 
level of restriction was a significant factor negatively 
influencing the levels of SOD (T = −2.77, p = 0.008) and 
an effect of circulating IGF-1 marginally failed to reach 
significance (T = −1.94, p = 0.059): overall least squares 
regression F
2,40
 = 3.87, p = 0.029, r2 = 0.162. The results of 
the OxyAdsorbent test revealed similar antioxidant power, 
ie oxidative defense system, between CR and AL fed mice 
(F
5,42
 = 0.88, p > 0.05). The levels of antioxidant power 
were not associated with any of the measured circulating 
hormones or masses of the different body compartments 
(multiple regression: all p > 0.05).
The analysis of 8-Hydroxy-2′-deoxyguanosine (8-
OHdG), as a marker of DNA damage in the liver, revealed 
no effect of CR treatment (One way ANOVA: F
5,47
 = 1.58, 
p > 0.05) (Figure 6a). Similarly liver protein carbonyl levels 
(protein damage) and F2-isoprostanes (lipid damage) were 
unaffected by the CR treatment (One way ANOVA: F
5,48
 = 
1.64, p > 0.05 and F
5,17
 = 1.849 p > 0.05 respectively; Figures 
6b and 6c). Nevertheless, levels of 8-OHdG were negatively 
associated with the circulating levels of leptin (T = −3.29, 
p = 0.002; Figure 6d) and positively associated with levels 
of circulating insulin (T = 3.01, p = 0.005; Figure 6e). The 
levels of protein carbonyls had a marginally significant 
negative association to the mass of structural tissue (T = 
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−2.10, p = 0.041) but were not significantly related to masses 
of any other body compartment or levels of circulating 
hormone levels. Levels of F2–isoprostanes were not related 
to variation in any parameters of body composition or 
circulating hormone levels. The circulating dROMs test 
primarily measures hydroperoxides in the blood. A significant 
treatment effect on dROMs (One way ANOVA: F
5,41
 = 5.83, p 
< 0.001) suggested increased ROM production in 20, 30 and 
40CR groups compared to the 12AL group (post hoc Tukey: 
p < 0.05). dROM levels were significantly positively 
associated with circulating levels of IL-6 (T = 2.75, p = 
0.009) and negatively associated with the mass of the 
reproductive organs (T = −3.39, p = 0.002): overall least 
squares regression F
2,34
 = 12.49, p < 0.0005, r2 = 0.424. 
No other hormone levels, masses of tissues or the level 
of restriction were significant in the multiple regression 
analysis. None of the markers of oxidative damage 
(8-OHdG, protein carbonyls, F2-isoprostanes and dROMs) 
Figure 3: a. Improvements in insulin sensitivity following calorie restriction (CR). Insulin sensitivity was estimated from 
the homeostatic assessment model (HOMA2), following 3 months of graded calorie restriction (CR) (10CR, 20CR, 30CR and 40CR) or 
control fed 12 hr or 24 hr ad libitum (12AL and 24AL). Not surprisingly very strong relationships were found between insulin and b. insulin 
sensitivity and c. insulin resistance. Different letters indicate significant differences between groups. Results are expressed as mean ± sem.
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were associated significantly to levels of any of the 
antioxidant enzymes (catalase, SOD and GPx) or antioxidant 
potential (OxyAdsorbent test), and unlike the antioxidant 
enzymes they were also not significantly correlated with each 
other (Pearson correlations: p > 0.05 in all cases). From these 
results we could infer patterns of association between levels 
of CR, body composition, circulating hormones and markers 
of oxidative stress (Figure 7).
Major urinary proteins (MUPs)
The CR treatment has a significant effect on the levels 
of the MUPs, a marker of reproductive performance (One way 
ANOVA: F
5,29
 = 13.01, p < 0.001; Figure 8a). The level of 
MUPs in the urine of mice undergoing restriction at levels of 
20CR and above was significantly lower than that of the 12AL 
group (post hoc Tukey: p < 0.001). MUP level was negatively 
related to degree of restriction (F
1,29
 = 73.33, p < 0.0005, r2 = 
0.72). In the multiple regression analysis the logged levels of 
MUPS were significantly associated with the total mass of 
the reproductive organs (F
1,29
 = 53.56, p < 0.0005, r2 = 0.65; 
Figure 8b). This effect was due to a significant relationship 
with the reproductive accessory organs (T = 6.76, p < 0.0005) 
rather than the testes (T = 1.21, p > 0.05).
Protein restriction (PR)
Hormones
No relationship between the concentration of 
circulating leptin and the level of dietary protein was 
observed (One way ANOVA: F
3,31
 = 1.022, p > 0.05) 
(Figure 9a). However, leptin levels were strongly related 
to the body fat mass (Figure 9b). Circulating insulin (One 
way ANOVA: F
3,31
 = 0.272, p > 0.05) and IGF-1 (One 
way ANOVA: F
3,31
 = 2.39, p > 0.05) were also unchanged 
by PR and at a similar level to that recorded in the AL 
animals (Figure 9c and 9d). Please note the same scales 
are used for PR and equivalent CR graphs.
Figure 4: A schematic diagram depicting the highly inter-related links between morphological and hormonal changes 
and glucose homeostasis. Positive relationships are shown in blue and negative in red, with increasing thickness of lines represent 
higher significance. Relationships were generated using stepwise least squared multiple regression models.
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Intraperitoneal glucose tolerance tests (IPGTT)
In complete contrast to the responses to CR, changes 
in the level of dietary protein did not affect any factors 
involved in the regulation of glucose homeostasis over the 
3 month treatment period, ie fasting glucose (GLM-RM, 
Time F
1,27
 = 0.017, p > 0.05 and level of CR F
3,27
 = 1.236, p 
> 0.05) and AUC (GLM-RM, Time F
1,27
 = 0.863, p > 0.05 
and level of CR F
3,27
 = 1.003, p > 0.05) (Figure 10a, 10b 
and 10c). Insulin sensitivity was also unaffected by PR 
(One way ANOVA, F
3,31
 = 0.600, p > 0.05) (Figure 10d).
Markers of oxidative stress
None of the 3 enzymatic antioxidants measured 
in the liver were influenced by PR (One way ANOVA, 
catalase: F
3,19
 = 0.438, p > 0.05, SOD: F
3,19
 = 2.382, p > 
0.05, and GPx: GPx F
3,19
 = 0.370, p > 0.05) (Figure 11a, 11b 
Figure 5: Changes in enzymatic antioxidant activity in the liver following calorie restriction (CR). a. catalase, b. superoxide 
dismutase (SOD), c. glutathione peroxidase (GPx) activity after 3 months of CR at varying levels. 10, 20, 30, 40% (10CR, 20CR, 30CR and 
40CR) compared to 12 hr or 24 hr ad libitum feeding (12AL and 24AL). The relationships between d. structural tissues and catalase and  
e. vital organs and GPx are shown. Different letters signify differences between groups. Data represented as mean ± sem.
Oncotarget23222www.impactjournals.com/oncotarget
Figure 6: Calorie restriction (CR) did not impact changes in oxidative damage in the liver. DNA, protein and lipid 
damage are shown as a. 8-Hydroxy-2′-deoxyguanosine (8-OHdG), b. protein carbonyls, c. F2-isoprostanes respectively. While a negative 
relationship between d. leptin levels and 8-OHdG was found e. insulin was positively linked to 8-OHdG. Mice underwent 3 months of 
graded CR, 10, 20, 30, 40% (10CR, 20CR, 30CR and 40CR), and were compared to 12 hr or 24 hr ad libitum feeding (12AL and 24AL). 
No differences were found between groups. Data represented as mean ± sem.
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Figure 7: A hypothetical diagram illustrating the interactions of morphological and hormonal changes subsequently 
linked to biomarkers of oxidative stress. Positive relationships are shown in blue and negative in red, with increasing thickness of 
lines represent higher significance. Significant relationships were generated using stepwise least squared multiple regression models.
Figure 8: The level of major urinary proteins (MUPs) were lowered following calorie restriction (CR). MUPs measured 
as an indication of the level of investment in reproduction was a. influenced by graded CR and b. strongly related to changes in reproductive 
organs. Significant differences between groups are indicated by different letters. Data shown as mean ± sem.
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and 11c). Similarly no changes in the circulating levels 
antioxidant capacity (One way ANOVA: F
3,30
 = 1.846, 
p > 0.05) were recorded (Figure 11d). No impact of 
PR was noted in the production of d-ROMs (One way 
ANOVA: F
3,31
 = 0.370, p > 0.05) (Figure 11e). No 
indication of protein damage due to the dietary treatment, 
as assessed by measurement of protein carbonyls, was 
observed (F
3,19
 = 0.660, p > 0.05) (Figure 11f).
Comparison of responses to calorie and protein 
restriction (CR vs PR)
To determine whether it was a reduction in calories 
or dietary protein that impacts the numerous health 
benefits reported with food restriction we drew direct 
comparisons between the protein matched diets, ie 40CR 
versus 40PR. Comparisons were first made between the 
Figure 9: Hormonal changes measured in male C57BL/6 mice following protein restriction (PR). PR at 20, 30 and 40% of ad 
libitum (AL) intake (20, 30, 40PR) does not affect circulating levels of a. leptin, c. insulin or d. insulin growth factor-1 (IGF-1) measured after 3 
months of PR. 12AL depicts control animals fed during 12 hours of darkness. The strong relationship between fat mass and leptin are shown in b. 
Data presented as mean ± sem. To illustrate differences between calorie restriction (CR) and PR, results are shown on the same axis as Figure 1.
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12AL groups from each study and bar two the majority 
of variables were statistically similar. Of the responses 
that did not match was fasting glucose (baseline fasting 
glucose: CR 11.01 ± 0.65 mmol/l vs PR 4.97 ± 0.15 
mmol/l, Independent t-test: t = 9.079, p < 0.001 and 
following 3months treatment: CR 10.57± 0.29 mmol/l 
vs PR 5.22 ± 0.49 mmol/l, Independent t-test: t = 9.367, 
p < 0.001). These differences between PR and CR can be 
explained by different lengths of fasting protocols and 
the absolute response to glucose, as measured by AUC, 
were similar between the 12AL controls of the CR and 
PR studies (baseline AUC: CR, 64.97 ± 2.98 vs PR, 
59.19 ± 1.43, Independent t-test: t = 1.745, p = 0.103 and 
following 3months treatment: CR 71.72 ± 4.70 vs PR, 
61.56 ± 4.27, t = 1.600, p > 0.05). Leptin levels were also 
marginally different between the two 12AL groups (CR 
3.9 ± 1.02 ng/ml versus PR 7.65 ± 1.34 ng/ml, Independent 
t-test: t = −2.168, p = 0.049). With the exception of protein 
carbonyls, comparisons of all other responses between the 
protein matched diets ie 20CR vs 20PR, 30CR vs 30PR 
Figure 10: The effect of graded levels of protein restriction (PR) on glucose homeostasis. a. Fasting glucose concentrations 
at baseline (BL) and following 3 months of PR (F). 20PR, 30PR and 40PR represent 20%, 30% and 40% PR. Control groups were fed 
ad libitum (AL) for 12 hrs (12AL). b. Glucose concentrations following glucose injection measured after 3 months graded PR, c. glucose 
tolerance calculated as area under the curve (AUC) and d. insulin sensitivity estimated from the homeostatic assessment model (HOMA2). 
Different letters within a time point indicate significant differences between groups. Data represented as mean ± sem. Results are shown 
on the same axis as Figure 2.
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Figure 11: Protein restriction (PR) did not impact changes in oxidative stress biomarkers in the liver. Antioxidant activity 
in the liver of a. catalase, b. superoxide dismutase (SOD), and c. glutathione peroxidase (GPx) was unchanged as was d. antioxidant 
capacity in the blood measured by OxyAdsorbent test (OxyD) following 3 months of graded PR. e. Protein damage as measured by protein 
carbonyls in the liver and f. reactive oxygen metabolites (dROMs) were not affected by PR reduced by 20, 30 or 40% (20PR, 30PR and 
40PR) compared to 12 hr ad libitum (12AL) fed C57BL/6 male mice. Data displayed as mean ± sem and shown on the same axis as Figures 
5 and 6 for ease of comparison of calorie restriction (CR) and PR.
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and 40CR vs 40PR were significantly different, which 
indicates that these changes were likely driven by energy 
shortfall rather than the protein deficit.
DISCUSSION
In all but a few of species [71], and some specific 
genetic backgrounds [72, 73], CR has been shown to 
alleviate age-related disease and extend lifespan. In the 
majority of studies examining CR, an incidental reduction 
in all macronutrients also occurs unless specifically 
compensated. One macronutrient implicated as potentially 
important in the CR effect is protein. Despite early research 
ruling out the impact of PR on the extension of lifespan, 
with low levels of protein apparently shortening lifespan 
[74–76], more recent studies have supported the notion that 
it is the restriction of protein that brings about the beneficial 
effects of CR and not the reduction in calories per se [77, 
78]. With an increasing awareness of the importance of 
nutritional intervention in a number of health parameters 
and the more recent use of the Nutritional Geometric 
Framework, a state-space nutritional modelling method 
[79], we investigated the independent effect of CR and 
PR on key biomarkers of healthspan [80] ie reductions in 
adiposity, improvements in insulin sensitivity, a decrease 
in the susceptibility to oxidative damage and changes in 
factors closely linked to energy balance and reproduction.
Key factors affecting the response to CR are the 
intensity, duration and time of initiation. Increases in the 
intensity and length of time on CR result in a positive linear 
relationship with survival [3, 81] while the introduction of 
CR early in life can detrimentally affect development [82]. 
We used diets graded in the level for CR or PR, initiated at 
5months of age (equivalent to early adulthood in humans), 
for a duration of 3 months in C57BL/6 mice. We have 
investigated a wealth of physiological, endocrinological, 
molecular and behavioral responses in these mice [18] (also 
Mitchell et al in prep).
Calorie restriction
Although CR impacted numerous body composition 
changes, these effects were not mimicked when protein 
only was restricted and calorie intake remained at the 
same level [18]. Results presented here confirm this was 
also true for a number of hormonal and metabolic factors. 
These results will be discussed within the context of four 
popular hypotheses explaining the mechanism by which 
CR mediates an extension in lifespan.
Reduction in body fat and resultant alterations 
in adipokine profiles
Under CR the deficit in energy must initially be 
attained by the utilization of tissues. We previously 
reported a preferential utilization of adipose tissue in 
these animals [18]. Over a series of studies investigating 
‘Nutrition and longevity’, Berg and Simms noted that ad 
libitum feeding led to obesity in rats [63, 83]. Recognizing 
that the reduction in fat mass observed in the CR mice 
was more favorable to health and disease development 
they proposed that it was the reduction in body fat that 
mediated the beneficial effects of CR on lifespan. This 
theory was dismissed following observations that the 
lowered fat mass of restricted rats was not a factor in life-
prolongation and despite being obese CR resulted in an 
extended lifespan in the ob/ob mouse [64, 65]. However, 
since the discovery of leptin [84] and the classification of 
adipose tissue as an endocrine organ, the reduction in body 
fat hypothesis has returned to favor [6, 7, 85, 86].
White adipose tissue serves multiple physiological 
functions and the reductions in adipose tissue found 
here under CR were strongly linked with decreases in 
circulating leptin levels. Leptin is produced and secreted 
in proportion to adipose tissue, reflecting the state of 
nutrition [84]. In agreement with previous reports [5] we 
found a preferential utilization of the visceral adipose 
depots (epididymal and retroperitoneal fat) as the level of 
CR increased [18]. Visceral adiposity is known as a major 
risk factor for type II diabetes, cardiovascular disease, and 
mortality [26, 87] and the surgical removal of visceral fat 
resulted in a dramatic improvement in insulin sensitivity 
together with a decrease in IGF binding protein-1 and 
a decrease in the expression of leptin and TNF-α in 
subcutaneous fat [26].
In the current study leptin levels were also linked 
to structural organs (which included carcass weight) and 
reproductive organ mass. This was unsurprising given the 
multi-functional role of leptin in the regulation of energy 
balance, inflammation, reproduction and bone formation 
[88]. Leptin is a major inhibitor of bone mass accrual 
[89]. Contrary to previous reports we found a beneficial 
effect of CR on bone mass [18] which may be related to 
reduction in levels of circulating leptin observed here. An 
association with leptin and the reproductive axis has also 
been well reported [90] with low levels of leptin associated 
with reduced fertility in both sexes. Here we also found 
that reduced levels of leptin were significantly associated 
with the levels of the Major Urinary Proteins (MUPs), 
a marker of reproductive investment in male mice. As a 
hormonal signal of available energy stores, leptin is an 
ideal candidate to mediate the trade-off between energy 
homeostasis and reproductive activity [91, 92].
In addition to leptin an ever expanding number of 
adipokines are produced by the adipose tissue eg TNF-α, 
and IL-6 are known to promote insulin resistance [96, 
97] which was corroborated here. Although classed as 
adipokines, these inflammatory cytokines are multi-
functional and here no direct relationship was found 
between TNF-α, IL-6 and resistin to the CR mediated 
decrease in fat mass. Reductions in TNF-α were dependent 
on the level of CR and not related to any morphological 
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changes. With elevated levels of IL-6 associated with type 
II diabetes and obesity [34] we anticipated a decrease 
in IL-6 with CR, however this was not evident here. 
Unexpectedly IL-6 levels recorded here were related to the 
changes in the alimentary tract, specifically the stomach. 
The relationship between resistin and structural tissues was 
also unexpected and CR did not reduce resistin levels as 
previously reported [95]. However, overall changes found 
in the circulating hormones measured here following 
3 months of CR were consistent with morphological 
changes. The gradation in CR intensity imposed the same 
manner of gradation in the circulating levels of leptin 
which may qualify leptin as a potential modulator of the 
anti-aging effects of CR as previously suggested [96, 97].
Insulin/insulin-like growth factor-1 (IGF-1) 
signaling pathway (IIS)
Here we found reductions in plasma insulin and 
IGF-1 following CR, strongly impacted on fasting glucose, 
with insulin also influencing insulin sensitivity and insulin 
resistance. Glucose tolerance, as measured by area under 
the curve (AUC) was significantly improved with CR, 
and unsurprisingly related to insulin. AUC was also 
related to reproductive organs, specifically the accessory 
organs. Enhanced insulin sensitivity is a key determinant 
of healthy aging thought to represent an important 
mechanism behind CR mediated longevity and is also 
characteristic of many of the long-lived mutant mice [36–
39]. Contradicting the hypothesis that an improvement in 
insulin sensitivity is responsible for enhanced longevity 
are the insulin receptor substrate-1 (IRS-1) knockout and 
Klotho mice [98, 99]. IRS-1 knockout females are longer 
lived with higher circulating insulin and impaired glucose 
tolerance in comparison to controls. While deletion of the 
Klotho gene resulted in reduced lifespan, overexpression 
significantly increased lifespan [98, 100]. However Klotho 
transgenic mice are IGF-1 and insulin resistant with 
elevated levels of IGF-1 and insulin.
One of the most popular pathways implicated in the 
CR-mediated increase in lifespan, is the nutrient-sensing 
pathway insulin/IGF-1 signaling pathway (IIS). A wealth 
of literature supports the notion that alterations in this 
evolutionarily conserved pathway can increase life span 
[101]. This has been demonstrated following the ablation 
of insulin producing cells, IGF-1, and their receptors in 
mice [35, 99, 102–104]. IGF-I is essential for growth 
and development which agrees with results found here, 
with IGF-1 strongly linked to the structural tissue mass. 
IGF-I has also been implicated as a major risk factor for 
the development of several different types of cancer. The 
reduced risk of age-related diseases, particularly cancer is 
associated with CR which could therefore be related to the 
reduced IGF-1. The administration of IGF-I in vivo increases 
the growth of tumors while decreases in IGF-1 levels results 
in a reduction of tumor growth [101, 105, 106].
Another means by which IIS may regulate lifespan is 
via a reduction of oxidative stress. This is clearly shown in 
C. elegans, where all single gene mutants of the nematode 
(>40) displaying increased lifespan had an improved 
resistance to oxidative stress [107]. While in rodents, the 
long lived dwarf mice, Ames and Snell as well as IGF-
1R+/– knockouts, all with an altered IIS, display stronger 
resistance to toxic attack from diaquat or paraquat [103, 
108, 109]. Stronger resistance implies an increased defense 
system which agrees with results here with IGF-1 negatively 
impacting upon GPx and SOD activity in the liver, ie IGF-
1 levels lowered via reduced structural tissue under CR 
leading to increased antioxidant activity (Figure 7).
The matching gradation found in response to the 
graded levels of CR is strongly supportive that lowered 
insulin and glucose, improvements in insulin sensitivity, 
together with reductions in IGF-1 are key to the anti-aging 
and life-prolonging effects of CR. However, although 
centenarians have low levels of IGF-1, it should be noted 
that the reduction in IGF-1 levels may not be applicable to 
humans, with short-term (6 days) [110] but not long-term 
(6 years) CR reducing circulating levels IGF-1 [111].
Attenuation of oxidative damage
Contrary to previous reports [15] we found a 
comprehensive decrease in the activity of the enzymatic 
antioxidants, superoxide scavenger, SOD, and the H2O2 
reducers’ catalase and GPx in the livers of mice following 
3 months CR. It is unclear whether antioxidant defense 
mechanisms are inducible or constitutive, with literature 
in support of both. Until recently evidence suggested 
antioxidants were inducible with the level of antioxidants 
increased in response to low level radiation [112], or the 
activation induced by H2O2 [113]. However employing 
microarrays, which comprised all known antioxidants 
Desaint and colleagues found no evidence of antioxidant 
regulation by H2O2 and concluded mammalian antioxidant 
defenses are constitutive [114]. Our data do not support the 
suggestion that these antioxidants work in a compensatory 
manner [115] ie as one increases the others decrease, with 
levels of all three antioxidants found to correlate strongly 
and positively. The oxidative stress theory predicts that 
the action of CR reduces damage from ROS through the 
activation of antioxidants [48, 49] but also refer to [52–54]; 
results here oppose this notion, but are in agreement with 
a study in non- and diabetic rats also undergoing a short, 9 
weeks, restriction at 40CR [116]. Although the antioxidants 
were strongly correlated to each other, interestingly they 
were individually related to separate morphological or 
hormonal changes. The link with IGF-1 gene deletion and 
increased resistance to oxidative stress was mentioned 
earlier and was corroborated here with a negative 
relationship between IGF-1 and SOD and, together with 
circulating TNF-α, GPx activity. Catalase and GPx were also 
linked independently to morphological changes resulting 
from the CR treatment. Catalase levels were associated 
Oncotarget23229www.impactjournals.com/oncotarget
positively to both the alimentary tract and structural organ 
masses. Despite the fact these antioxidants were measured 
in the liver, the weight of which was included in the vital 
organs, only GPx levels were positively associated to these 
organs. However our results suggest a mismatch of the 
oxidative defense system in liver compared to blood, in that 
antioxidant capacity (measured by OxyD) was unchanged 
following CR and unrelated hormonally or morphologically.
Obesity has been linked to the diminished activity 
of antioxidants [117] and also high oxidative stress 
[118, 119], if the opposite was to be true and fitting 
with the FRTA then following CR we would anticipate 
an increase in antioxidants (negative) and decrease in 
oxidative stress (positive relationship). As reported 
above antioxidant activity was lowered here. Regarding 
markers of oxidative stress only 2 direct relationships 
with morphological changes and oxidative damage were 
found; firstly, structural tissues and protein damage 
and secondly reproductive organs and dROMs. With 
the high protein content of muscle a connection with 
protein damage, as measured by protein carbonyls, may 
be anticipated; however both these relationships were 
negative therefore we again dismiss the attenuation of 
oxidative stress theory.
A positive relationships linking CR to oxidative 
stress was found between IL-6 and dROMs. In addition a 
positive relationship between insulin and the DNA damage 
marker (8OHdG) was noted however this was opposed by 
a negative link to leptin levels. In support of our findings, 
insulin was shown to induce free radicals production 
[120] and reverse the lowering of ROS production via CR 
[121] . Lambert et al suggested lowered insulin levels and 
alterations in insulin signaling may be important to lower 
the production of ROS [121]. The negative effect of leptin 
on DNA damage is unclear but leptin was previously shown 
to directly stimulate the production of ROS [122, 123]. 
However, like the antioxidants some conflicting reports 
exist [124]. In contrast to our results the majority of studies 
indicated a reduction by CR in the age-related increase in 
oxidative damage to DNA [125]. Sohal’s 1994 study clearly 
demonstrated an age-related increase in 8-OHdG in skeletal 
muscle, brain, heart, liver and kidney and the concentration 
of 8-OHdG, in all 5 tissues, was reduced by 40% CR 
compared to ad libitum fed mice [13]. However it should 
be noted that the duration of CR in the study of Sohal was 
15months thus the lack of effect noted here may merely be 
an indication of our short term study [13].
The age related increase in the level of protein 
carbonylation and F2-isoprostanes, markers of damage 
to proteins and membrane phospholipids, in the liver 
and kidney was previously shown to be reduced by CR 
[126, 127]. However, here no effect at any level of CR 
was found on the levels of liver protein carbonyls or F2-
isoprostanes which again may be related to the short-term, 
3 months, exposure to CR. However the lack of oxidative 
damage found in the liver was opposed with increased 
levels of dROMs measured in the blood, an indication of 
increased oxidative stress. It should be stressed that the 
measurement of oxidative damage is critically dependent 
on the biomarker measured and the tissues used [128, 129].
The decreased activity of antioxidants found here 
could be interpreted as reflecting a reduced state of 
oxidative stress ie less antioxidants are produced as only 
low levels of ROS are present, thus maintaining levels of 
damage constant. Reducing antioxidants in the face of 
less damage might conserve energy. However this does 
not fully correspond with our results as no correlations 
were evident between the antioxidants and damage to 
DNA, protein or lipid samples from liver. Although we 
cannot conclude on CR effect on lifespan extension, 
overall results found here do not support the attenuation 
of oxidative stress theory as a fundamental mechanism 
impacting the beneficial effects of short-term CR.
Reproductive trade-off
CR is known to reduce fertility, a response that 
some have hypothesized to have evolved allowing 
animals to survive periods of food scarcity by shutting 
down reproduction and investing all available energy into 
survival [62, 69]. To compensate for energy restriction 
animals must withdraw energy from body tissues (detailed 
elsewhere [18]). We have previously shown that although 
the testes were included in tissues ‘protected’ following 
CR, the reproductive accessory organs were one of the 
preferentially utilized tissues. These included the preputial 
glands where farnesenes, which are linked to male sexual 
signaling, are produced [59]. Also important are MUPs, 
involatile proteinaceous scent components found in urine. 
For males, scent marking to attract females comes at a 
cost, with substantial investment in protein synthesis and 
resultant oxidative damage. However mixed results in house 
mice found that although increased oxidative damage was 
measured in the muscle of males under heightened stress 
of breeding in the vicinity of competitors, higher oxidative 
damage in the liver and serum was measured in males 
under no such stress [130]. Here the decrease in accessory 
organ mass together with the reduction in MUPs indicated 
a decrease in scent marking activity under CR and hence 
reduced reproductive investment. This was consistent 
with the suggestion that diversion of energy away from 
reproduction towards somatic protection is a key factor 
involved in the life enhancing effects of CR. These changes 
in MUPs were mostly closely linked to the size of the 
accessory organs, size which unlike testes declined under 
increased levels of CR [18].
Protein restriction (PR)
Although a number of studies have reported 
increases in maximum longevity following PR [82, 131], 
here we found no changes in any of the parameters we 
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measured that have been previously implicated in the 
longevity effects of CR. Improvements in insulin sensitivity 
is a key characteristic of CR that was not replicated 
by PR. The lack of response in the levels of IGF-1 and 
adipokines were unsurprising given the body composition 
of PR mice remained unchanged [18]. One of the most 
highly reported ideas behind the life extending effects 
of PR is the attenuation of oxidative stress. PR has been 
shown to exert life extending effects through a decrease 
in the accumulation of oxidative damage and increase 
in antioxidant defenses [126, 132, 133] (also see recent 
review [134]), however no such changes were found here. 
In fact the accumulation of oxidatively damaged proteins 
was found to be of a similar magnitude in mice fed the PR 
diets compared to mice fed the protein matched CR diets.
In addition to PR, restriction of the essential 
amino acid methionine (MR) has also been reported to 
enhance longevity, potentially mediated via impacts such 
as lowered serum glucose, insulin and IGF-I plus an 
increased resistance to oxidative damage [132, 135, 136]. 
Interestingly, unlike PR, changes in body composition, 
particularly reduced visceral fat, accompanied MR with 
subsequent reduction in insulin, glucose and leptin [137]. 
Although some believe MR to play a contributory role in 
CR effects, comparisons of gene expression profiles do not 
significantly overlap, suggesting independent pathways 
between CR and MR [138].
Why our results do not encapsulate those previously 
shown following PR is unclear. The restricted diets in this 
study were specifically formulated to match the level of 
protein used in our CR study (16, 14 and 12% protein). 
There is a possibility the level of PR was not stringent 
enough as studies where PR has shown a life extending 
effect the diet contained a range from ~5 to 15%, protein, 
although the levels used here were at the top end of the 
range they were still within the range [131, 139]. However, 
consistent over the studies was that in the cases where 
PR did extend lifespan, this was to a lower extent of that 
demonstrated by CR, with PR only accounting for ~50% of 
the life-extending effect of CR [136]. It should be noted that 
studies looking at the response to reductions in dietary fat 
[140] or carbohydrate [141] without an overall energy deficit 
also do not replicate the beneficial effects related to CR.
CONCLUSIONS
None of the four theories emerged as solely 
explaining the beneficial effects of CR. Instead, we 
identified a highly inter-related network of responses 
supporting three of the four theories: i) body fat reduction, 
ii) modulation of insulin sensitivity and the IIS pathway, 
and iii) reproductive investment trade-offs. CR influenced 
hormonal changes; in particular reductions in leptin and 
TNF-α. Both these hormones were reduced in a graded 
manner relative to the level of CR with leptin specifically 
linked to reductions in fat mass, structural tissues and 
reproductive organs. How the reduction in leptin might 
contribute to the aging process is not fully understood. 
We know that disruption of leptin signaling and leptin 
resistance plays a critical role in obesity, a major risk 
factor for morbidity and mortality, and obesity-related 
disease such as impaired glucose metabolism, cancer, and 
the development of cardiovascular disease. Improvements 
in insulin sensitivity and modulation of the IIS pathway 
and the subsequent increase in lifespan are much better 
understood with pathways conserved from worms to 
humans [142]. The hypothesis that CR decreases oxidative 
damage and increases antioxidant enzyme levels was not 
supported here. Differences between studies, duration, diet 
composition and severity of CR are all important factors 
which need to be taken into account, as well as tissues and 
assays used. Our results do however unequivocally show 
that, in the short-term, 3-month PR does not replicate the 
changes observed with CR and this may be attributed to 
the lack of change in body composition changes under PR.
MATERIALS AND METHODS
Animals
All procedures were reviewed and approved by 
University of Aberdeen ethical approval committee and 
carried out under the Animals (Scientific Procedures) Act 
1986. A detailed description of the experimental procedures 
has previously been published [18]. Briefly, male C57BL/6 
mice (Charles River, Ormiston, UK) were individually 
housed on a 12:12 h light/dark cycle with free access to 
water and food (D12450B, Research Diets, NJ, USA). 
Body mass (BM) and food intake (FI) were recorded 
daily, immediately prior to feeding. Full details of the 
body composition responses are reported elsewhere [18]. 
To overcome obesity issues typical of ad libitum (AL) fed 
control groups with 24 hr access to food (24AL) [143], an 
additional control group (0%CR) fed only in the 12 hrs of 
darkness (12AL) was introduced, ie mice were fed at 1830 
and food was removed at 0630. This not only counteracted 
overeating, but also ensured mice were in a similar hunger 
state at the time of kill, ~4 hrs prior to lights out.
Following a 2 week baseline period, a 3 month 
restriction period (CR or PR) was initiated at 5 months of 
age, approximately equivalent to human early adulthood. 
The 3 month restriction period was equivalent to around a 
tenth of their lifespan, comparable to ~8 years for humans. 
For the CR study mice were randomly allocated into the 
following groups (n = 7–9): 0, 10, 20, 30 or 40% CR (termed 
12AL, 10CR, 20CR 30CR and 40CR). Restricted FI’s were 
calculated based on individual FI over the baseline period. 
Mice on the CR study were fed D12450B, 20% protein, 
70% carbohydrate and 10% fat (by energy), throughout. We 
found that mice responded to restriction by enlarging their 
alimentary tracts and increasing digestive efficiency [18] 
and hence realized levels of restriction were slightly lower 
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than the nominal levels. All mice on the PR study received 
D12450B over the baseline period. This was replaced by 
modified diets during the restriction period, where protein 
content was reduced to 16, 14 and 12% matching the protein 
levels in the 20, 30 and 40CR groups without a reduction 
in calories, termed 20PR, 30PR and 40PR, respectively 
(D13020201, D13020202 and D13020203 respectively, 
Research Diets, NJ, USA). Mice in the PR study were 
prevented from overeating by feeding a fixed level of food 
daily based on their individual baseline intake. Control mice 
in the PR study were fed the D12450B throughout ie 20% 
protein, but again restricted to the hours of darkness.
At 8 months of age, after 3 months restricted feeding, 
the mice were killed by a terminal CO2 overdose. Cardiac 
puncture blood samples were divided between Heparin 
and EDTA treated tubes (BD Bioscience, UK) and later 
centrifuged for plasma collection. All remaining tissues were 
rapidly removed (~8 mins) weighed, divided appropriately 
for future analysis and snap frozen in liquid nitrogen. The 
liver was quickly divided into 7 pieces and individually 
frozen in cryovials to avoid freeze/thaw artefacts.
Plasma assays
To avoid the level of hunger affecting the 
concentration of adipokines and hormones measured, all 
mice were fasted prior to kill. Food was removed from 
both the 12 and 24AL groups at 0630 on the day prior 
to the kill at ~1400–1700 h. Circulating insulin, leptin, 
tumor necrosis factor (TNF)-α, resistin and interleukin 
(IL)-6 were measured in plasma at the end of 3 month 
restriction period using the MilliplexTM mouse adipokine 
panel (MADPK-71K, Millipore, Watford, UK). Fasted 
plasma IGF-1 was detected using a mouse specific 
Enzyme Linked Immunoassay (ELISA) (R&D Systems 
Europe Ltd, Abingdon, UK).
Intraperitoneal glucose tolerance tests (IPGTT) 
and the homeostatic model assessment (HOMA2)
IPGTT were performed twice, firstly during baseline 
then after ~11 weeks of restriction. Mice were fasted for at 
least 8 hours prior to IPGTT. Fasted glucose was measured 
from tail blood immediately prior to a 2 mg/g intraperitoneal 
glucose injection. Following injection glucose was measured 
at 15, 30, 60 and 120 minutes using Johnson and Johnson’s 
OneTouch® Ultra Blood Glucose Monitoring System. Insulin 
sensitivity and insulin resistance were evaluated according to 
the HOMA2 Calculator© (The University of Oxford) (fasting 
blood glucose (mmol/L) × fasting insulin (μU/ml)/22.5) using 
fasting glucose measurements taken immediately prior to kill.
Biomarkers of oxidative damage
As a measure of oxidative stress DNA, lipid and 
protein damage was evaluated in the liver along with the 
activity of antioxidants, catalase, glutathione peroxidase 
(GPx) and superoxide dismutase (SOD) in the blood. To 
note, in the PR study only 5 liver samples from each group 
were analyzed. Protocols are briefly described below.
8-Hydroxy-2′-deoxyguanosine (8-OHdG) levels, 
widely used as biomarker of oxidative DNA damage, were 
measured using the Highly Sensitive Competitive ELISA 
kit (Japan Institute for the Control of Aging (JAICA), 
Shizuoka, Japan). The intra-assay and inter-assay variations, 
as reported by the manufacturer, were 1.4–2.1% and 1.9–
7.1%. To decrease the risk of artificial DNA oxidation, the 
extraction process was optimized to include sodium iodide 
and enzymatic DNA digestion [144]. Protein Carbonyls were 
measured by ELISA (BioCell, Papatoetoe, New Zealand) 
[145]. The measurement of liver F2-isoprostanes was carried 
out at the Barshop Institute for Longevity and Aging Studies at 
the University of Texas Health Science Center at San Antonio 
under the kind supervision of Wenbo Qi in the lab of Holly 
Van Remmen. The process involves lipid extraction, thin 
layer chromatography (TLC) purification, and quantification 
by gas chromatography-mass spectrometric analysis and is 
explained in full detail elsewhere [127]. Antioxidant enzyme 
activities were measured using direct spectrophotometric 
methods. First homogenates from ~50 mg of liver were 
prepared in ice-cold 50 mM phosphate buffer (PB) (pH7.4), 
centrifuged and supernatants collected. All reactions were 
carried out in triplicate and absorbance read at 25°C using 
the SpectraMax Plus384 spectrophotometer with SoftMax 
software. Catalase activity was measured on the day of 
homogenization following the methodology of Cohen [150]. 
Incubation with 1% Triton X ensured the release of catalase 
activity from the peroxisomes. Samples were run alongside 
blank (buffer) and standard (water) reactions. 6 mM hydrogen 
peroxide (H2O2) was added to sample and blank followed by 
2 mM potassium permanganate to all. Reactions were stopped 
after 3 min by the addition of 3 M sulphuric acid. The residual 
potassium permanganate color from the catalase driven 
peroxidation was measured at 480 nm at 25ºC. Glutathione 
peroxidase (GPx) activity was determined by a modification 
of the method of Paglia and Valentine [151]. Reaction 
mixtures consisted of 1 mM Ethylenediaminetetraacetic 
acid (EDTA), 4 mM sodium azide, 0.2 mM Nicotinamide 
adenine dinucleotide 2-phosphate reduced tetrasodium salt 
hydrate (NADPH), 1.083 U/ml glutathione reductase and 4 
mM reduced glutathione in ice cold 50 mM PB. Reactions 
were initiated by the addition of H2O2 and monitored for 1min 
at 340 nm. Absorbances were recorded in a quartz cuvette 
at 340 nm and activity calculated from the oxidation rate of 
NADPH to NADP. One GPx unit is directly proportional 
to the amount of NADPH consumed in nmol per minute at 
23–25°C. Total superoxide dismutase (SOD) activity was 
measured using a method originally described by [148]. The 
assay is based on the rapid inhibition of the auto-oxidation 
of pyrogallol (1,2,3-benzenetriol) by SOD. Reactions were 
performed in a 50 mM Trizma buffer containing 1 M of the 
iron chelator diethylenetriaminepentaacetic acid (DPTA). 
The reaction rate, in the presence and absence of sample, 
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was measured as the change in absorbance at 420 nm over a 
2 minute interval. This method cannot determine between 
the different forms of SOD, ie CuZn, Mn and FE SODs. 
Specific antioxidant activities were calculated on the basis 
of concentration of protein per assay. Protein content was 
detected using the Bradford assay [149]. Standard curves were 
created from known concentrations of bovine serum albumin 
(BSA). Briefly Bradford Reagent Working solution (BioRad, 
Hemel Hempstead, UK) was added to 10 μl of sample, in 
a 96 well plate, and absorbance read at 595 nM. Plasma 
antioxidant potential and reactive oxygen metabolites (ROM) 
were evaluated in plasma samples using the OXY-Adsorbent 
(OxyD) and d-ROM kits respectively (Diacron international, 
Grossetto, Italy). Antioxidant power is expressed as μmol of 
HCIO/ml and ROMs, primarily hydroperoxides, results are 
expressed as Carratelli Units (CARR U).
Major urinary proteins (MUPs)
Urine was collected immediately prior to kill by 
scruffing the mice over a Petri dish and gently massaging 
the bladder. Urine samples were transferred to eppendorfs 
and stored at −20°C. MUPs were measured using 
methods previously described in detail elsewhere [130, 
150]. Briefly, the concentration of urinary protein was 
assessed using the Coomassie plus® protein assay reagent 
kit (Perbio Science, UK). Samples were then analyzed by 
SDS-PAGE gels to confirm that urinary protein consisted 
of MUPs rather than other proteins that had leaked through 
the glomerular filter [134].
Statistical analyses
Statistical analyses were performed using the PASW 
Statistics package 18, Minitab 16 and the R statistical 
environment. Data was first checked for normality using 
the Kolmogorov-Smirnov test and log transformed where 
appropriate. One way ANOVA was used for comparison 
between groups following the 3 month diet treatment. A 
general linear model with repeated measures (GLM-RM) 
was used to compare data across the restriction period, 
ie baseline versus following 3 months of CR (F). Paired t-
tests were used where appropriate and post hoc Tukey tests 
compared differences between the 6 diet groups at specified 
time points. We have shown previously [18] that graded CR 
results in a cascade of effects on the sizes of different body 
compartments, including adipose tissue, structural tissues 
such as skeletal muscle, reproductive organs and to a lesser 
extent the vital organs. Using these body composition data, 
from the same animals, measured after 3 months of restriction, 
we sought to explore the roles of these downstream effects 
on body composition on the resultant changes in the levels 
of circulating hormones. To do this we included the level of 
restriction (as a continuous variable) and the masses of the 
different body compartments (log transformed as necessary) 
as independent predictors in stepwise least squared multiple 
regression models, with sequential backward deletion. We did 
not force the models by default to include any parameters. 
When we found a significant effect of an overall body 
compartment (e.g. white adipose tissue) we performed 
further analyses including as predictors the components that 
contributed to the total weight of that tissue compartment 
(for example, in the case of white adipose tissue including 
the mesenteric fat, retroperitoneal fat, epididymal fat and 
subcutaneous fat depot weights as independent predictors). 
With respect to glucose homeostasis and oxidative stress 
biomarkers we included the downstream effects of restriction 
on body composition and circulating hormone levels as 
predictors in the regression models. Type III sums of squares 
were used in all models. This analytical approach makes 
the assumption that the predictor variables are independent, 
and this assumption was clearly violated in our data, since 
the downstream body composition changes, resulting in 
particular from CR, were co-ordinated across the different 
tissues and correlated with each other [18]. Nevertheless, this 
analysis provides a first tentative step towards understanding 
the potential causal relationships that occur downstream of 
the initial experimental manipulation of restriction level.
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